Atrial Fibrillation registry to Follow the long-teRm Outcomes and the use of aNTIcoagulants aftER Ablation

Atrial Fibrillation registry to Follow the long-teRm Outcomes and the use of aNTIcoagulants aftER Ablation - AF Frontier Ablation Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026849

Enrollment

3400

Registered

2017-04-04

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent atrial fibrillation ablation before January 1, 2012, and were followed-up at least 1 year after the ablation.

Exclusion criteria

Exclusion criteria: 1) Patients contraindicated for direct oral anticoagulants 2) Patients who had acute myocardial infartion or stroke/TIA within 2 months before ablation 3) Patients judged as inappropriate for this study by investigators

Design outcomes

Primary

Measure	Time frame
Composite of symptomatic stroke (ischemic or hemorrhagic) and systemic embolism	—

Secondary

Measure	Time frame
Discontinuation of anticoagulant drugs Atrial fibrillation recurrence after the blanking period Major adverse cardiac events (myocardial infarction/unstable angina pectoris and heart failure) All cause of death Major bleeding(adapeted ISTH standard)	—

Countries

Japan

Contacts

Public ContactOkumura Yasuo

Division of Cardiology, Department of Medicine, Nihon University School of Medicine Nihon University Itabashi Hospital

okumura.yasuo@nihon-u.ac.jp+81-3-3972-8111

Outcome results